Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis

Significance of follow-up left ventricular ejection fraction measurements in the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation trial (DEFINITE)

(2013) Jorge E. Schliamser et al.   HEART RHYTHM

Late gadolinium enhancement on cardiac magnetic resonance images predicts reverse remodeling in patients with nonischemic cardiomyopathy treated with carvedilol

(2013) Keisuke Kida et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators

(2012) Brian P. Betensky et al.   HEART RHYTHM

Implantable Cardioverter Defibrillator Therapy in Patients with Cardiac Sarcoidosis

(2012) JOSEPH L. SCHULLER et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Arrhythmias in cardiac sarcoidosis

(2011) Pablo B. Nery et al.   CURRENT OPINION IN CARDIOLOGY

18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis

(2011) Hiroshi Ohira et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment

(2011) G. Youssef et al.   HEART

Sarcoidosis

(2011) Michael C. Iannuzzi   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Need for Standardization of 18F-FDG PET/CT for Treatment Response Assessments

(2011) R. Boellaard   JOURNAL OF NUCLEAR MEDICINE

Standards for PET Image Acquisition and Quantitative Data Analysis

(2009) R. Boellaard   JOURNAL OF NUCLEAR MEDICINE